drugset / Trial / NCT03966235

Melatonin on Coronary Artery Calcification

NCT03966235

Phase 4 Unknown 74 enrolled Chinese PLA General Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

We planned to evaluate the effects of melatonin on progression of coronary artery calcification (CAC) in patients with moderate calcified coronary atherosclerosis.

Timeline

Start
2019-06-01
Primary completion
2021-06-01
Completion
2021-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 3 mg Oral